Kroger, DocuSign And Other Big Gainers From Friday
U.S. stocks closed higher with the Nasdaq Composite surging 250 points on Friday. Here is the list of some big stocks recording gains in the previous session.
Volatility In Markets Drops After US Stocks Record Weekly Gains
U.S. stocks recorded gains on Friday, with the major indices on the Wall Street notching their first weekly surge in four weeks.
Markets are now awaiting August's consumer prices data, due on Tuesday, to look out for any signs of easing in inflation level. Annual inflation is seen declining to an 8.1% rate in August, compared to 8.5% in July.
US Consumer Inflation Expectations Likely To Ease Further, Here Are The Major Macro Issues For Monday
U.S. stocks closed higher on Friday with the Nasdaq Composite gaining 250 points amid a rise in Amazon.com, Inc. (NASDAQ: AMZN) and Apple Inc. (NASDAQ: AAPL) shares.
Bitcoin Surges Past $22,000, Here Are Other Crypto Movers That Should Be On Your Radar Today
Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, recorded gains, topping the $22,000 level this morning.
Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Large Premarket Seller For Kroger Shares Spotted Friday: Trading The Grocer’s Q2 Earnings
There are several critical aspects of the PreMarket Prep show that no other financial media has even a clue about. One of those is interpreting order flow and the price action in premarket and after-hours trading.
After Disappointing Data, Allakos Discontinues Work On Lirentelimab In Eosinophilic Gastrointestinal Diseases
Allakos Inc (NASDAQ: ALLK) has reported data from the EoDyssey Phase 3 study of lirentelimab in patients with eosinophilic duodenitis (EoD).
Novartis’ Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
Novartis AG (NYSE:NVS) has announced results from a new pooled exploratory analysis of the MONALEESA Phase 3 program of Kisqali +…